Intervention
Methoxyamine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownTesting the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerNCT05198830 · 2022-12-15
ACTIVE_NOT_RECRUITINGMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinNCT02535312 · 2016-03-08
ACTIVE_NOT_RECRUITINGMethoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerNCT02535325 · 2015-09-30
COMPLETEDCommon conditions
Advanced Malignant Solid Neoplasm1Advanced Peritoneal Malignant Mesothelioma1Advanced Pleural Malignant Mesothelioma1Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma1Lung Adenocarcinoma1Lung Large Cell Carcinoma1Lung Non-Squamous Non-Small Cell Carcinoma1Recurrent Peritoneal Malignant Mesothelioma1Recurrent Pleural Malignant Mesothelioma1Refractory Malignant Solid Neoplasm1Stage III Lung Adenocarcinoma AJCC v71Stage III Lung Cancer AJCC v81Stage III Lung Large Cell Carcinoma AJCC v71Stage III Lung Non-Small Cell Cancer AJCC v71Stage IIIA Lung Adenocarcinoma AJCC v71Stage IIIA Lung Large Cell Carcinoma AJCC v71Stage IIIA Lung Non-Small Cell Cancer AJCC v71Stage IIIB Lung Adenocarcinoma AJCC v71Stage IIIB Lung Large Cell Carcinoma AJCC v71Stage IIIB Lung Non-Small Cell Cancer AJCC v71Stage IV Lung Adenocarcinoma AJCC v71Stage IV Lung Large Cell Carcinoma AJCC v71Stage IV Lung Non-Small Cell Cancer AJCC v71Unresectable Solid Neoplasm1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING2
COMPLETED1
Phase mix
PHASE12
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.